HelixNano

Using mRNA to modify biology at the push of a button

First Investment: 2017

HelixNano is developing new ways to manipulate messenger RNA, the molecule that delivers information from genes to the cell’s protein factories. One of HelixNano’s advances makes mRNA vaccines more targeted and more powerful; the company is using this technique to advance a mutation-resistant, second-generation vaccine against the SARS-CoV‑2 virus that causes Covid-19.

Explore Companies

Noetik

Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer

Solu Therapeutics

Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules

Samsara Eco

Sparing the climate through infinite recycling of plastic waste

Nium

Making green ammonia for fertilizer and energy transport